DekaBank Deutsche Girozentrale’s Caribou Biosciences CRBU Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-130,000	Closed	-$724K	–	1168
2025 Q4	$724K	Hold	130,000	–	–	﹤0.01%	937
2025 Q3	$716K	Hold	130,000	–	–	﹤0.01%	928
2025 Q2	$723K	Hold	130,000	–	–	﹤0.01%	919
2025 Q1	$666K	Hold	130,000	–	–	﹤0.01%	913
2024 Q4	$630K	Hold	130,000	–	–	﹤0.01%	957
2024 Q3	$666K	Hold	130,000	–	–	﹤0.01%	954
2024 Q2	$666K	Hold	130,000	–	–	﹤0.01%	956
2024 Q1	$666K	Hold	130,000	–	–	﹤0.01%	951
2023 Q4	$764K	Buy	+130,000	New	+$643K	﹤0.01%	954
2022 Q3	–	Sell	-24,200	Closed	-$135K	–	1388
2022 Q2	$135K	Buy	+24,200	New	+$185K	﹤0.01%	1251
2022 Q1	–	Sell	-22,000	Closed	-$321K	–	1351
2021 Q4	$321K	Buy	+22,000	New	+$428K	﹤0.01%	1184

Other funds holding CRBU

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DekaBank Deutsche Girozentrale's CRBU Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Caribou Biosciences (CRBU) in Q1 2026, closing a stake of 130,000 shares — an estimated $724K sold.

DekaBank Deutsche Girozentrale first reported a position in CRBU in Q4 2021 and held it in 11 quarters. The position peaked at $764K in Q4 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Caribou Biosciences position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 130,000 Caribou Biosciences shares in Q1 2026, an estimated $724K.
DekaBank Deutsche Girozentrale first reported a position in Caribou Biosciences in Q4 2021 and held it in 11 quarters.
DekaBank Deutsche Girozentrale's Caribou Biosciences position peaked at $764K in Q4 2023.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.